Buprenorphine now replaces methadone as the most common medicine for opioid dependence’: 10-year trends in opioid agonist treatment medicines in Australia
National Drug & Alcohol Research Centre Blog
DECEMBER 4, 2023
In Australia, both methadone and buprenorphine have been subsidised by the Pharmaceutical Benefit Scheme (PBS) for the treatment of opioid dependence (termed ‘opioid agonist treatment’ or OAT) for several decades. Our recent article, published in The International Journal of Drugs , presents the Australia-wide results. Chidwick, K.,
Let's personalize your content